National Pension Service Has $213.86 Million Stake in Zoetis Inc. $ZTS

National Pension Service grew its position in Zoetis Inc. (NYSE:ZTS) by 4.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,371,358 shares of the company’s stock after buying an additional 52,376 shares during the quarter. National Pension Service owned 0.31% of Zoetis worth $213,863,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ZTS. Nuveen LLC acquired a new position in Zoetis during the first quarter valued at approximately $616,375,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Zoetis by 113.0% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock valued at $586,671,000 after acquiring an additional 1,995,491 shares during the last quarter. Mackenzie Financial Corp grew its position in Zoetis by 4,158.3% in the first quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock valued at $300,481,000 after acquiring an additional 1,782,110 shares during the last quarter. Polen Capital Management LLC raised its stake in Zoetis by 17.6% during the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock worth $1,448,401,000 after acquiring an additional 1,313,653 shares in the last quarter. Finally, Amundi lifted its holdings in shares of Zoetis by 30.8% in the first quarter. Amundi now owns 3,595,628 shares of the company’s stock worth $575,691,000 after acquiring an additional 846,909 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on ZTS. Morgan Stanley decreased their price target on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a report on Monday. Argus reiterated a “buy” rating and issued a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Stifel Nicolaus set a $140.00 price objective on Zoetis in a research report on Tuesday, November 4th. UBS Group dropped their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $180.00.

Zoetis Stock Performance

Shares of ZTS stock opened at $121.30 on Thursday. The stock has a market capitalization of $53.45 billion, a PE ratio of 20.88, a PEG ratio of 2.31 and a beta of 0.90. The business’s 50 day simple moving average is $142.21 and its 200 day simple moving average is $151.94. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. Zoetis Inc. has a one year low of $117.26 and a one year high of $181.85.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.42 billion. During the same quarter last year, the business earned $1.58 EPS. The company’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.